LW-213   Click here for help

GtoPdb Ligand ID: 11177

Synonyms: compound 18c [PMID: 28987604] | LW213
Compound class: Synthetic organic
Comment: LW-213 is a derivative of the plant flavinoid wogonin [2], and like its parent it has anticancer activity [1,3-4]. Studies in human cutaneous T-cell lymphomas (CTCL) indicate that LW-213-induced apoptosis is mediated via activation of the PERK-eIF2α-ATF4-CHOP axis, and involves enhanced reactive oxygen species production and calcium-dependent endoplasmic reticulum stress. The primary molecular target of LW-213 has not been defined.
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 1
Hydrogen bond donors 1
Rotatable bonds 9
Topological polar surface area 72.14
Molecular weight 445.19
XLogP 5.96
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CN(CCCOc1c(OCc2ccccc2)cc(c2c1oc(cc2=O)c1ccccc1)O)C
Isomeric SMILES CN(CCCOc1c(OCc2ccccc2)cc(c2c1oc(cc2=O)c1ccccc1)O)C
InChI InChI=1S/C27H27NO5/c1-28(2)14-9-15-31-26-24(32-18-19-10-5-3-6-11-19)17-22(30)25-21(29)16-23(33-27(25)26)20-12-7-4-8-13-20/h3-8,10-13,16-17,30H,9,14-15,18H2,1-2H3
InChI Key CZZGXKYKSUTFEU-UHFFFAOYSA-N
References
1. Liu X, Hu P, Li H, Yu XX, Wang XY, Qing YJ, Wang ZY, Wang HZ, Zhu MY, Guo QL et al.. (2020)
LW-213, a newly synthesized flavonoid, induces G2/M phase arrest and apoptosis in chronic myeloid leukemia.
Acta Pharmacol Sin, 41 (2): 249-259. [PMID:31316178]
2. Wang J, Ge R, Qiu X, Xu X, Wei L, Li Z, Bian J. (2017)
Discovery and synthesis of novel Wogonin derivatives with potent antitumor activity in vitro.
Eur J Med Chem, 140: 421-434. [PMID:28987604]
3. Yu XX, Zhu MY, Wang JR, Li H, Hu P, Qing YJ, Wang XY, Wang HZ. (2020)
LW-213 induces cell apoptosis in human cutaneous T-cell lymphomas by activating PERK-eIF2α-ATF4-CHOP axis.
Acta Pharmacol Sin,. DOI: 10.1038/s41401-020-0466-7 [PMID:32747719]
4. Zhao L, Miao HC, Li WJ, Sun Y, Huang SL, Li ZY, Guo QL. (2016)
LW-213 induces G2/M cell cycle arrest through AKT/GSK3β/β-catenin signaling pathway in human breast cancer cells.
Mol Carcinog, 55 (5): 778-92. [PMID:25945460]